Cargando…
Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
AIM: In order to develop a possible tracer for L-type calcium channel imaging, we here report the development of a Ga-68 amlodipine derivative for possible PET imaging. MATERIALS AND METHODS: Amlodipine DOTA conjugate was synthesized, characterized and went through calcium channel blockade, toxicity...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041414/ https://www.ncbi.nlm.nih.gov/pubmed/27833311 http://dx.doi.org/10.4103/0972-3919.190797 |
_version_ | 1782456408095064064 |
---|---|
author | Firuzyar, Tahereh Jalilian, Amir Reza Aboudzadeh, Mohammad Reza Sadeghpour, Hossein Shafiee-Ardestani, Mahdi Khalaj, Ali |
author_facet | Firuzyar, Tahereh Jalilian, Amir Reza Aboudzadeh, Mohammad Reza Sadeghpour, Hossein Shafiee-Ardestani, Mahdi Khalaj, Ali |
author_sort | Firuzyar, Tahereh |
collection | PubMed |
description | AIM: In order to develop a possible tracer for L-type calcium channel imaging, we here report the development of a Ga-68 amlodipine derivative for possible PET imaging. MATERIALS AND METHODS: Amlodipine DOTA conjugate was synthesized, characterized and went through calcium channel blockade, toxicity, apoptosis/necrosis tests. [(68)Ga] DOTA AMLO was prepared at optimized conditions followed by stability tests, partition coefficient determination and biodistribution studies using tissue counting and co incidence imaging up to 2 h. RESULTS: [(68)Ga] DOTA AMLO was prepared at pH 4–5 in 7–10 min at 95°C in high radiochemical purity (>99%, radio thin layer chromatography; specific activity: 1.9–2.1 GBq/mmol) and was stable up to 4 h with a log P of −0.94. Calcium channel rich tissues including myocardium, and tissues with smooth muscle cells such as colon, intestine, and lungs demonstrated significant uptake. Co incidence images supported the biodistribution data up to 2 h. CONCLUSIONS: The complex can be a candidate for further positron emission tomography imaging for L type calcium channels. |
format | Online Article Text |
id | pubmed-5041414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50414142016-11-11 Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging Firuzyar, Tahereh Jalilian, Amir Reza Aboudzadeh, Mohammad Reza Sadeghpour, Hossein Shafiee-Ardestani, Mahdi Khalaj, Ali Indian J Nucl Med Original Article AIM: In order to develop a possible tracer for L-type calcium channel imaging, we here report the development of a Ga-68 amlodipine derivative for possible PET imaging. MATERIALS AND METHODS: Amlodipine DOTA conjugate was synthesized, characterized and went through calcium channel blockade, toxicity, apoptosis/necrosis tests. [(68)Ga] DOTA AMLO was prepared at optimized conditions followed by stability tests, partition coefficient determination and biodistribution studies using tissue counting and co incidence imaging up to 2 h. RESULTS: [(68)Ga] DOTA AMLO was prepared at pH 4–5 in 7–10 min at 95°C in high radiochemical purity (>99%, radio thin layer chromatography; specific activity: 1.9–2.1 GBq/mmol) and was stable up to 4 h with a log P of −0.94. Calcium channel rich tissues including myocardium, and tissues with smooth muscle cells such as colon, intestine, and lungs demonstrated significant uptake. Co incidence images supported the biodistribution data up to 2 h. CONCLUSIONS: The complex can be a candidate for further positron emission tomography imaging for L type calcium channels. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5041414/ /pubmed/27833311 http://dx.doi.org/10.4103/0972-3919.190797 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Firuzyar, Tahereh Jalilian, Amir Reza Aboudzadeh, Mohammad Reza Sadeghpour, Hossein Shafiee-Ardestani, Mahdi Khalaj, Ali Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging |
title | Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging |
title_full | Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging |
title_fullStr | Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging |
title_full_unstemmed | Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging |
title_short | Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging |
title_sort | preparation and preclinical evaluation of (68)ga-dota-amlodipine for l-type calcium channel imaging |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041414/ https://www.ncbi.nlm.nih.gov/pubmed/27833311 http://dx.doi.org/10.4103/0972-3919.190797 |
work_keys_str_mv | AT firuzyartahereh preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging AT jalilianamirreza preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging AT aboudzadehmohammadreza preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging AT sadeghpourhossein preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging AT shafieeardestanimahdi preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging AT khalajali preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging |